سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Promoter Methylation and Expression Status of Cytotoxic T-Lymphocyte-Associated Antigen-4 Gene in Patients with Lupus

Publish Year: 1400
Type: Journal paper
Language: English
View: 184

This Paper With 7 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_JEPUSB-2-1_005

Index date: 3 July 2022

Promoter Methylation and Expression Status of Cytotoxic T-Lymphocyte-Associated Antigen-4 Gene in Patients with Lupus abstract

Objectives: Systemic lupus erythematous (SLE) is an autoimmune disease with both genetic susceptibility and epigenetic modifications. Autoantibodies directly contribute to the destruction of some organs such as kidneys, joints, skin, lungs, central nervous system, and blood-forming (hematopoietic) system. The CTLA4 plays an important role in inhibition of the activity of T cells and preventing autoimmune disorders, for example; the lupus. We analyzed the promoter methylation, polymorphism, and expression status in CTLA4 gene in patients with lupus. Methods: Genomic DNA was isolated from 50 individuals’ blood samples with SLE and 50 control participants. CTLA4 gene polymorphisms analysis in polymorphic site, -318(CT) and +49(AG), was done by Tetra-ARMS-PCR. Methylation-specific polymerase chain reaction (MS-PCR) was used to estimate promoter hyper methylation of the CTLA4 gene. The present paper also analyzed CTLA4 mRNA levels in 30 blood samples from the intended participants, and healthy control by real-time PCR. Results: Changes in promoter methylation of CTLA4 gene were remarkably different in patients with lupus than healthy controls (OR= 0.48; 95% CI= 0.1959, 1.202; P-value= 0.005). However, gene expression level of CTLA4 was not statistically different in patients than the healthy control group. Conclusions: This epigenetic study gives us an overview of the role of CTLA4 promoter methylation in pathogenesis of SLE, which cause preventing its expression. As we know CTLA4 has the role in immune regulation and downregulates immune responses. In the future a comprehensive understanding of the epigenetic mechanisms contributing to SLE will likely enable development of new therapeutic agents and strategies that target the dysregulated genes or correct the aberrant epigenetic modifications (Epigenetic therapies for SLE).

Promoter Methylation and Expression Status of Cytotoxic T-Lymphocyte-Associated Antigen-4 Gene in Patients with Lupus Keywords:

Promoter Methylation and Expression Status of Cytotoxic T-Lymphocyte-Associated Antigen-4 Gene in Patients with Lupus authors

Shahin Nosrat zehi

Department of internal medicine, Zahean university of medical science, Zahedan, Iran

Mahin Nosrat zehi

Department of internal medicine, Zahean university of medical science, Zahedan, Iran

Sahar Atighi

Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran

Tahereh Dianat

Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran

Khadije Kord Tamandani

Department of internal medicine, Zahean university of medical science, Zahedan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Achtman, J. C., & Werth, V. P. (۲۰۱۵). Pathophysiology of ...
Altorok, N., & Sawalha, A. H. (۲۰۱۳). Epigenetics in the ...
Ballestar, E., Esteller, M., & Richardson, B. C. (۲۰۰۶). The ...
Bengtsson, A., & Rönnblom, L. (۲۰۱۷). Systemic lupus erythematosus: still ...
Cojocaru, M., Cojocaru, I. M., Silosi, I., & Vrabie, C. ...
Cunningham, M., & Gilkeson, G. (۲۰۱۱). Estrogen receptors in immunity ...
Dariavach, P., Mattéi, M. G., Golstein, P., & Lefranc, M. ...
Davatchi, F., Jamshidi, A.-R., Banihashemi, A. T., Gholami, J., Forouzanfar, ...
Foster, M. H. (۲۰۰۷). T cells and B cells in ...
Ghodke-Puranik, Y., & Niewold, T. B. (۲۰۱۵). Immuno- genetics of ...
Grimaldi, C. M. (۲۰۰۶). Sex and systemic lupus erythematosus: the ...
Harley, I. T., Kaufman, K. M., Langefeld, C. D., Harley, ...
Iraji, R., Arish, M., Aminifard, M., & Dianat, T. (۲۰۱۹). ...
Javierre, B. M., Fernandez, A. F., Richter, J., Al-Shahrour, F., ...
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, ...
Kordi-Tamandani, D. M., Vaziri, S., Dahmardeh, N., & Torkamanzehi, A. ...
Liu, Z., & Davidson, A. (۲۰۱۲). Taming lupus—a new understanding ...
Lu, Q., Kaplan, M., Ray, D., Ray, D., Zacharek, S., ...
Maidhof, W., & Hilas, O. (۲۰۱۲). Lupus: an overview of ...
Mohan, C., & Putterman, C. (۲۰۱۵). Genetics and pathogenesis of ...
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., ...
Niewold, T. B. (۲۰۱۵). Advances in lupus genetics. Current opinion ...
Patel, D. R., & Richardson, B. C. (۲۰۱۰). Epigenetic mechanisms ...
Relle, M., Weinmann-Menke, J., Scorletti, E., Cavagna, L., & Schwarting, ...
Schur, P. (۱۹۹۵). Genetics of systemic lupus erythematosus. Lupus, ۴(۶), ...
Sestak, A. L., Fürnrohr, B. G., Harley, J. B., Merrill, ...
Shao, W.-H., & Cohen, P. L. (۲۰۱۱). Disturbances of apoptotic ...
Shelly, S., Boaz, M., & Orbach, H. (۲۰۱۲). Prolactin and ...
Shojaa, M., Aghaie, M., Khashayar, P., Amoli, M., Qorbani, M., ...
Vyse, T., & Kotzin, B. (۱۹۹۸). Genetic susceptibility to systemic ...
Yang, J. C., Hughes, M., Kammula, U., Royal, R., Sherry, ...
Zhan, Y., Guo, Y., & Lu, Q. (۲۰۱۶). Aberrant Epigenetic ...
نمایش کامل مراجع